Introduction
Nasal Polyps (Nasal Polyposis) - Overview
Nasal Polyps (Nasal Polyposis) - Therapeutics Development
Nasal Polyps (Nasal Polyposis) - Therapeutics Assessment
Nasal Polyps (Nasal Polyposis) - Companies Involved in Therapeutics Development
Nasal Polyps (Nasal Polyposis) - Drug Profiles
Nasal Polyps (Nasal Polyposis) - Dormant Projects
Nasal Polyps (Nasal Polyposis) - Discontinued Products
Nasal Polyps (Nasal Polyposis) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Nasal Polyps (Nasal Polyposis), H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by AnaptysBio Inc, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by GlaxoSmithKline Plc, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Idorsia Pharmaceutical Ltd, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Kyowa Kirin Co Ltd, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Novartis AG, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by OptiNose US Inc, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Pfizer Inc, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Regeneron Pharmaceuticals Inc, H1 2020
Nasal Polyps (Nasal Polyposis) - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, H1 2020
Nasal Polyps (Nasal Polyposis) - Dormant Projects, H1 2020
Nasal Polyps (Nasal Polyposis) - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Nasal Polyps (Nasal Polyposis), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• AnaptysBio Inc
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline Plc
• Idorsia Pharmaceutical Ltd
• Kyowa Kirin Co Ltd
• Novartis AG
• OptiNose US Inc
• Pfizer Inc
• Regeneron Pharmaceuticals Inc
• Suzhou Connect Biopharmaceuticals Ltd